Medication info
Lamon Tablets (Terbinafine Hydrochloride)

Lamon Tablets (Terbinafine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Dongku Bio Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200301101 · Notified 2003.08.19 · Insurance code 657301200

Summary

Main use
Treatment of onychomycosis, dermatomycosis (such as tinea pedis and tinea corporis), and tinea capitis in children
Who takes it
Adults · Children
Adult dose
Administer 125 mg of terbinafine twice daily or 250 mg once daily. The duration of administration according to condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toenails, or in younger patients, the treatment duration may be shortened to 3 months or less. A treatment duration of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. The treatment duration may be longer in patients with slow nail growth. For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
Child dose
Administer to children aged 2 years and older. Administration is not recommended in children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for an appropriately prescribed duration. Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.

Ingredients

Manufacturer
Dongku Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, dermatomycosis (such as tinea pedis and tinea corporis), and tinea capitis in children

  • Dermatophytosis caused by dermatophytes
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used to treat dermatophytosis caused by dermatophytes in adults, such as tinea pedis, tinea corporis, and tinea cruris, as well as onychomycosis. It is also effective for the treatment of tinea capitis in children. Therefore, it helps alleviate fungal infections in the skin and nails.

How to take

Adult dose

Administer 125 mg of terbinafine twice daily or 250 mg once daily. The duration of administration according to condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toenails, or in younger patients, the treatment duration may be shortened to 3 months or less. A treatment duration of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. The treatment duration may be longer in patients with slow nail growth. For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.

Child dose

Administer to children aged 2 years and older. Administration is not recommended in children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for an appropriately prescribed duration. Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.

Precautions

This medication should preferably not be used in patients with chronic liver disease or active liver disease. Before taking this medication, it is imperative to confirm liver health status, and regular liver function tests should be conducted. If symptoms of liver dysfunction, persistent nausea, fatigue, jaundice, etc., occur, notify a doctor immediately and discontinue this medication. This medication can have serious effects on liver function; therefore, if liver failure is suspected, use should be stopped immediately and professional examination should be sought. It should not be used in individuals who have had an allergic reaction to this medication or those with blood disorders, severe renal impairment, children under 2 years of age, or nursing women. In cautious cases, it should be administered carefully to individuals with impaired renal function, elderly patients, or young children with low body weight. If skin rashes or serious skin reactions occur, use should be stopped immediately. This medication can cause various side effects, including gastrointestinal disturbances, headaches, dizziness, and depression, so any symptoms should be discussed with healthcare professionals. Precautions should be taken when driving or operating machinery, as side effects such as dizziness may occur. There may be drug interactions when taken with other medications, so it is necessary to inform your doctor of all medications you are currently taking, and dose adjustments may be needed as appropriate. Women who are pregnant or may become pregnant should carefully weigh the benefits and risks of using this medication, and nursing mothers should discontinue breastfeeding while on this medication. In case of overdose, symptoms such as headaches, nausea, and dizziness may occur. If suspected, seek immediate medical attention for appropriate treatment. This medication should be stored out of the reach of children and kept in a tightly sealed container away from direct sunlight at room temperature.

Side effects

Liver and biliary dysfunction, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, fatigue, increased γ-GTP, increased AST/ALT, increased LDH, increased ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-like rash, psoriasis exacerbation, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, increased CPK, elevated serum myoglobin, increased myoglobin in urine, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, gastrointestinal symptoms, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory disturbances, sensory loss, reduced attention, insomnia, elevated BUN, polyuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, increased serum total cholesterol, elevated triglycerides, fatigue, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased visual acuity, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, eosinophilia, drug eruption, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it at a temperature between 1°C and 30°C. Storing it in this manner helps maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.